Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
D000227:Adenine Nucleotides; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000032:analysis* / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010743:Phospholipids / Q000097:blood*; D011422:Propionates / Q000627:therapeutic use*
D000227:Adenine Nucleotides; D000924:Anticholesteremic Agents; D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D010743:Phospholipids; D011422:Propionates; D002784:Cholesterol; D002994:Clofibrate